| Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ... The Lancet 397 (10269), 99-111, 2021 | 5264 | 2021 |
| Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review … T Shi, DA McAllister, KL O'Brien, EAF Simoes, SA Madhi, BD Gessner, ... The Lancet 390 (10098), 946-958, 2017 | 2098 | 2017 |
| Efficacy of the ChAdOx1 nCoV-19 Covid-19 vaccine against the B. 1.351 variant SA Madhi, V Baillie, CL Cutland, M Voysey, AL Koen, L Fairlie, ... New England Journal of Medicine 384 (20), 1885-1898, 2021 | 1369 | 2021 |
| Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four … M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ... The Lancet 397 (10277), 881-891, 2021 | 1327 | 2021 |
| SARS-CoV-2 Omicron-B. 1.1. 529 leads to widespread escape from neutralizing antibody responses W Dejnirattisai, J Huo, D Zhou, J Zahradník, P Supasa, C Liu, ... Cell 185 (3), 467-484. e15, 2022 | 897 | 2022 |
| Reduced neutralization of SARS-CoV-2 B. 1.617 by vaccine and convalescent serum C Liu, HM Ginn, W Dejnirattisai, P Supasa, B Wang, A Tuekprakhon, ... Cell 184 (16), 4220-4236. e13, 2021 | 740 | 2021 |
| Efficacy of NVX-CoV2373 Covid-19 vaccine against the B. 1.351 variant V Shinde, S Bhikha, Z Hoosain, M Archary, Q Bhorat, L Fairlie, U Lalloo, ... New England Journal of Medicine 384 (20), 1899-1909, 2021 | 673 | 2021 |
| Causes of severe pneumonia requiring hospital admission in children without HIV infection from Africa and Asia: the PERCH multi-country case-control study KL O'Brien, HC Baggett, WA Brooks, DR Feikin, LL Hammitt, MM Higdon, ... The Lancet 394 (10200), 757-779, 2019 | 515 | 2019 |
| Global patterns in monthly activity of influenza virus, respiratory syncytial virus, parainfluenza virus, and metapneumovirus: a systematic analysis Y Li, RM Reeves, X Wang, Q Bassat, WA Brooks, C Cohen, DP Moore, ... The Lancet Global Health 7 (8), e1031-e1045, 2019 | 325 | 2019 |
| RSV Global Epidemiology Network. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young … T Shi, DA McAllister, KL O’Brien, EAF Simoes, SA Madhi, BD Gessner, ... Lancet 390 (10098), 946-958, 2017 | 171 | 2017 |
| Oxford COVID Vaccine Trial Group Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in … M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ... Lancet 397 (10269), 99-111, 2021 | 133 | 2021 |
| Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in people living with and without HIV in South Africa: an interim analysis of a randomised … SA Madhi, AL Koen, A Izu, L Fairlie, CL Cutland, V Baillie, ... The Lancet HIV 8 (9), e568-e580, 2021 | 129 | 2021 |
| Density of Upper Respiratory Colonization With Streptococcus pneumoniae and Its Role in the Diagnosis of Pneumococcal Pneumonia Among Children Aged <5 … HC Baggett, NL Watson, M Deloria Knoll, WA Brooks, DR Feikin, ... Clinical Infectious Diseases 64 (suppl_3), S317-S327, 2017 | 115 | 2017 |
| Safety and efficacy of the ChAdOx1 nCoV-19 (AZD1222) Covid-19 vaccine against the B. 1.351 variant in South Africa SA Madhi, V Baillie, CL Cutland, M Voysey, AL Koen, L Fairlie, ... MedRxiv, 2021.02. 10.21251247, 2021 | 103 | 2021 |
| Initial findings from a novel population-based child mortality surveillance approach: a descriptive study AW Taylor, DM Blau, Q Bassat, D Onyango, KL Kotloff, S El Arifeen, ... The Lancet Global Health 8 (7), e909-e919, 2020 | 103 | 2020 |
| Association of C-reactive protein with bacterial and respiratory syncytial virus–associated pneumonia among children aged< 5 years in the PERCH study MM Higdon, T Le, KL O’Brien, DR Murdoch, C Prosperi, HC Baggett, ... Clinical infectious diseases 64 (suppl_3), S378-S386, 2017 | 103 | 2017 |
| Global burden of acute lower respiratory infection associated with human metapneumovirus in children under 5 years in 2018: a systematic review and modelling study X Wang, Y Li, M Deloria-Knoll, SA Madhi, C Cohen, A Ali, S Basnet, ... The Lancet Global Health 9 (1), e33-e43, 2021 | 91 | 2021 |
| Is higher viral load in the upper respiratory tract associated with severe pneumonia? Findings from the PERCH study DR Feikin, W Fu, DE Park, Q Shi, MM Higdon, HC Baggett, WA Brooks, ... Clinical Infectious Diseases 64 (suppl_3), S337-S346, 2017 | 88 | 2017 |
| Colonization density of the upper respiratory tract as a predictor of pneumonia—Haemophilus influenzae, Moraxella catarrhalis, Staphylococcus aureus, and Pneumocystis jirovecii DE Park, HC Baggett, SRC Howie, Q Shi, NL Watson, WA Brooks, ... Clinical infectious diseases 64 (suppl_3), S328-S336, 2017 | 66 | 2017 |
| Standardization of laboratory methods for the PERCH study AJ Driscoll, RA Karron, SC Morpeth, N Bhat, OS Levine, HC Baggett, ... Clinical Infectious Diseases 64 (suppl_3), S245-S252, 2017 | 61 | 2017 |
